Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dacarbazine citrate is an alkylating agent used to treat cancers of the lymphatic system and malignant melanoma (a type of skin cancer) in patients with certain conditions: islet cell carcinoma (part of the pancreas) Soft tissue sarcoma (cancer of muscles, tendons, blood vessels carrying blood or lymph, joints, and fat).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | Dacarbazine citrate is an alkylating agent used to treat cancers of the lymphatic system and malignant melanoma (a type of skin cancer) in patients with certain conditions: islet cell carcinoma (part of the pancreas) Soft tissue sarcoma (cancer of muscles, tendons, blood vessels carrying blood or lymph, joints, and fat). |
別名 | DTIC citrate |
分子量 | 374.31 |
分子式 | C12H18N6O8 |
CAS No. | 64038-56-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dacarbazine citrate 64038-56-8 Dacarbazine Citrate DTIC Citrate DTIC citrate Inhibitor inhibitor inhibit